TITLE

Reliability and validity of the Geriatric Depression Scale in depression in Parkinson's disease

AUTHOR(S)
Ertan, F. S.; Ertan, T.; Kızıltan, G.; Uyguçgil, H.
PUB. DATE
October 2005
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Oct2005, Vol. 76 Issue 10, p1445
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The objective of this study was to investigate reliability and validity of the self rated 30 item Geriatric Depression Scale (GDS) in screening and diagnosis of depression in Parkinson's disease (PD). The study sample comprised 109 non-demented patients with PD admitted to the movement disorders outpatient unit. The reference diagnosis of depression was made according to DSM-IV criteria. Discriminant validity and internal consistency of the total scale were studied. Sensitivity, specificity, and positive and negative predictive values (PPV and NPV) were calculated for different cutoff scores. Receiver operating characteristics (ROC) analysis was also carried out. The sample comprised 56 patients with and 53 without depression. In the discriminant validity analysis, the mean total GDS score of subjects with depression was significantly higher compared with those without depression. The Cronbach's α score was 0.92 and the split half correlation coefficient 0.91. The cutoff score of 13/14 provided the highest sum of sensitivity and specificity level. The sensitivity of this cutoff score was 0.78 and specificity 0.85, while PPV was 0.84 and NPV 0.79. The area under the curve value in the ROC analysis was 0.891. Sensitivity and specificity analysis showed that cutoff scores of 8/9 or 9/10 could be useful for screening and 14/15 or 15/16 for diagnostic purposes. This study showed that the 30 item GDS, with its high discriminant validity, internal consistency, and reasonably clear cutoff scores, could be a useful screening or diagnostic self rated depression scale in patients with PD.
ACCESSION #
18530744

 

Related Articles

  • The journey: Parkinson's disease. Baker, Mary G.; Graham, Lizzie // BMJ: British Medical Journal (International Edition);9/11/2004, Vol. 329 Issue 7466, p611 

    Offers a clinical review on Parkinson's disease. Development of the disease which differs from patient to patient; The line between offering hope and communicating that the disease is incurable; Multidisciplinary help for patients; Charter of rights from the European Parkinson's Disease...

  • Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines. Grosset, D. G.; Macphee, G. J. A.; Nairn, M. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/23/2010, Vol. 340 Issue 7739, p206 

    The article presents a summary of Scottish Intercollegiate Guideline Network (SIGN) guidelines on the diagnosis and drug management of Parkinson's disease. The bases for diagnosis of the disease are enumerated including the presence of a specific set of clinical features. A hospital physician...

  • Diagnosis and treatment of psychogenic parkinsonism. Jankovic, Joseph // Journal of Neurology, Neurosurgery & Psychiatry;Dec2011, Vol. 82 Issue 12, p1300 

    Parkinson's disease (PD) is the most common movement disorder encountered in movement disorder clinics but psychogenic parkinsonism (PP) is relatively rare. Based on a study of 32 patients, coupled with a comprehensive review of the literature, the diagnosis, clinical phenomenology,...

  • Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a I-FP-CIT SPECT study. Giuda, Daniela; Camardese, Giovanni; Bentivoglio, Anna; Cocciolillo, Fabrizio; Guidubaldi, Arianna; Pucci, Lorella; Bruno, Isabella; Janiri, Luigi; Giordano, Alessandro; Fasano, Alfonso // European Journal of Nuclear Medicine & Molecular Imaging;Dec2012, Vol. 39 Issue 12, p1937 

    Purpose: Psychiatric symptoms frequently occur in patients with movement disorders. They are not a mere reaction to chronic disability, but most likely due to a combination of psychosocial factors and biochemical dysfunction underlying the movement disorder. We assessed dopamine transporter...

  • Cognitive and Affective Impairment in Parkinson Disease - A B.I.N. Experience. Ghosh, T.; Das, S. K.; Basu, J.; Mishra, A. // Annals of Indian Academy of Neurology;2007 Supplement 2, Vol. 10, p43 

    Background: The presence of cognitive and affective impairments in Parkinson's disease is well-documented around the world. There is paucity of work on this subject in Indian medical literature. Objective: To determine the cognitive and affective impairments in patients with Idiopathic...

  • Depression in Patients with Parkinson's Disease: Epidemiology, Pathophysiology and Treatment Options. Zesiewicz, T.A.; Hauser, R.A. // CNS Drugs;2000, Vol. 13 Issue 4, p253 

    The evaluation and treatment of depression is an important component of the management of individuals with Parkinson's disease. This review summarises current knowledge on the epidemiology, pathophysiology and treatment of depression in Parkinson's disease. Limited information is available...

  • Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. Nin P S Bajaj // Journal of Neurology, Neurosurgery & Psychiatry;Nov2010, Vol. 81 Issue 11, p1223 

    BACKGROUND: This study examines the clinical accuracy of movement disorder specialists in distinguishing tremor dominant Parkinson's disease (TDPD) from other tremulous movement disorders by the use of standardised patient videos. PATIENTS AND METHODS: Two movement disorder specialists were...

  • CITATIONS AND CLINICIANS' NOTES: MOVEMENT DISORDERS.  // Current Medical Literature: Neurology;2005, Vol. 21 Issue 1, p10 

    This article presents information on movement disorders. A pilot study reports on the Testosterone deficiency and apathy in Parkinson's disease from Pittsburgh, in the U.S. In order to study the relationship between free serum testosterone levels and apathy in elderly men with Parkinson's...

  • Wearing-off in Parkinson's disease: neuropsychological differences between on and off periods. Caillava-Santos, Fabiane; Margis, Regina; de Mello Rieder, Carlos Roberto // Neuropsychiatric Disease & Treatment;2015, Vol. 11, p1175 

    Background: Levodopa-associated motor fluctuations are common complications observed in Parkinson's disease (PD) patients. Although nonmotor fluctuations are a significant cause of morbidity, they frequently are not properly identified. Few studies have characterized the nonmotor emotional...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics